SOCS1 and lung carcinoma: Our study revealed that miR-6794-5p inhibits SOCS1 expression at the cellular level by directly binding to it and confirmed that SOCS1 was expressed at a lower level in plasma samples from patients with lung cancer than in normal groups (Fig. 3).